<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>KFF Health News</provider_name><provider_url>https://kffhealthnews.org</provider_url><author_name>khnsstapleton</author_name><author_url>https://kffhealthnews.org/news/author/khnsstapleton/</author_url><title>Trump Presses Senate To Pass Bill Aimed At Ending Shipments Of Synthetic Opioids Into The U.S. - KFF Health News</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="6B3SmXKx1s"&gt;&lt;a href="https://kffhealthnews.org/morning-breakout/trump-presses-senate-to-pass-bill-aimed-at-ending-shipments-of-synthetic-opioids-into-the-u-s/"&gt;Trump Presses Senate To Pass Bill Aimed At Ending Shipments Of Synthetic Opioids Into The U.S.&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://kffhealthnews.org/morning-breakout/trump-presses-senate-to-pass-bill-aimed-at-ending-shipments-of-synthetic-opioids-into-the-u-s/embed/#?secret=6B3SmXKx1s" width="600" height="338" title="&#x201C;Trump Presses Senate To Pass Bill Aimed At Ending Shipments Of Synthetic Opioids Into The U.S.&#x201D; &#x2014; KFF Health News" data-secret="6B3SmXKx1s" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script type="text/javascript"&gt;
/* &lt;![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
/* ]]&gt; */
&lt;/script&gt;
</html><description>The bill, the Synthetics Trafficking and Overdose Prevention Act, has already been passed by the House but a group of eight health industry groups oppose part of the measure. Specifically, America's Health Insurance Plans, the Blue Cross Blue Shield Association and other groups are pushing back against a provision that would require private insurance plans to pay more to cover kidney disease before Medicare becomes the primary payer. The change is meant to offset the costs of the bill, which includes a range of steps designed to counter the opioid epidemic.</description></oembed>
